Back to News

Relay Therapeutics joins IQ Consortium

Relay Therapeutics joins IQ Consortium

March 31, 2022

The IQ Consortium is pleased to announce its newest member, Relay Therapeutics, a clinical-stage precision medicine company that sits at the intersection of computational and experimental technologies.

Relay Thereapeutics will be represented on the IQ Board of Directors by Mahesh Padval.